newsfilter
← Latest News
Business Wire·

New Publication Establishes Strong Clinical Validation of Signatera™ for MRD Assessment in Lymphoma

Signatera demonstrates 100% positive predictive value for treatment response assessment, detects recurrence months earlier than imaging, and supports precise, individualized lymphoma management through serial ctDNA